IBG vs NIVF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 24, 2026

IBG

60.2
AI Score
VS
IBG Wins

NIVF

31.6
AI Score

Investment Advisor Scores

IBG

60score
Recommendation
STRONG BUY

NIVF

32score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric IBG NIVF Winner
Forward P/E 0 0.0071 Tie
PEG Ratio 0 0 Tie
Revenue Growth -38.6% -4.7% NIVF
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 60.2/100 31.6/100 IBG
Profit Margin -223.4% 24.2% NIVF
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY EXTENDED IBG

Relative Price Performance (Last 90 Days)

IBG 1M: -9.8% · 3M: -4.9% NIVF 1M: +169.9% · 3M: +39.0%

Current Technical Phase

IBG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 49.2 · Price: $0.87

NIVF

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 77

RSI (14): 76.8 · Price: $1.46

Fundamentals Snapshot

Metric IBG NIVF
Market Cap — —
Forward P/E -17.4 0.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.4% 0.0%
Gross Margin 0.4% 0.2%
Operating Margin -2.4% -1.8%
EPS -13.56 -26766.46
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, IBG is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.